Aghajanian C
No ORCID on file
· 5 papers in corpus
· active 2014-2024
Study types
- other 1
Condition tags
- endometriosis 1
Top journals
Frequent coauthors
- Chi DS 2
- Abu-Rustum NR 2
- Weigelt B 2
- Grisham RN 2
- Bashashati A 1
- Breen K 1
- Andrea E Wahner-Hendrickson 1
- Birrer MJ 1
- Catchings A 1
- Bookman MA 1
2024
ObjectivesMesonephric (MA) and mesonephric-like (MLA) adenocarcinomas are rare cancers, and data on clinical behavior and response to therapy are limited. We sought to report molecular features, treatment, and outcomes of MA/MLA from a sing…
other
2023
OBJECTIVE: Gynecologic cancers are traditionally managed according to their presumed site of origin, without regard to the underlying histologic subtype. Clear cell histology is associated with chemotherapy refractoriness and poor survival.…
2022
Pathogenic germline variants underlie up to 20% of ovarian cancer (OC) and are associated with varying degrees of risk for OC. For mutations in high-penetrance genes such as BRCA1/2, the role of risk-reducing bilateral salpingo-oophorectomy…
2019
ObjectiveEndometrioid ovarian carcinomas (EOCs) comprise 5-10% of all ovarian cancers and commonly co-occur with synchronous endometrioid endometrial cancer (EEC). We sought to examine the molecular characteristics of pure EOCs in patients …
2014
The Ovarian Task Force of the Gynecologic Cancer Steering Committee convened a clinical trials planning meeting on October 28-29, 2011, with the goals to identify key tumor types, associated molecular pathways, and biomarkers for targeted d…